Scottsdale, Arizona, July 13, 2021 – McapMediaWire – NOHO, Inc. (OTC PINK: DRNK), a Wyoming corporation (the “Company”), announced the following:


The Company has retained the firm, Farber Hass Hurley LLP, Certified Public Accountants, to conduct PCAOB required audits of its financial statements for the prior two years.  Upon completion of the audits, the Company will file the required applications to return to fully reporting status with the SEC.


The Company is pleased to announce the installation of Mr. James D. Staudohar and Mr. Booker T. Evans, J.R., to the Company’s Board of Directors.  Messrs. Staudohar and Evans both currently serve as directors on the board of Sibannac, Inc. (OTC Pink: SNNC).

Booker T. Evans, Jr., Esq., Director

Mr. Evans is a renowned trial attorney, having been a member of some of the leading law firms in the country over one of the most distinguished legal careers, concentrated in  commercial litigation, white- collar criminal defense and product liability.

He has been named to Arizona’s Finest Lawyers, a Super Lawyer in White Collar Criminal Defense, a Top 100 Trial Lawyer and a Best Lawyer in America by US News & World Report.  Prior to entering private practice, Mr. Evans served as a Chief Deputy District Attorney in Las Vegas, Assistant United States Attorney in Nevada and Arizona, and Corporate Counsel for Arizona Public Service Company.

James D. Staudohar, Director and Chairman of the Audit Committee

Mr. Staudohar is a veteran of corporate finance, having served in senior management for successful public companies and private enterprise for over 40 years.

Jim has served as Chief Financial Officer of several companies, including Best Products in 1983, then a billion-dollar retail organization.  Prior to that, he served as Vice President and Controller of B. Dalton Bookseller.  Mr. Staudohar served on the Board of Directors of Smith & Wesson Holding Corporation from 2002-2004, where he was the Chair of the Audit Committee.


The Company has received the packaging for the new After Shot and the product will be ready for sale in the coming weeks.  The new sales site will also be completed concurrent with the receipt of the new inventory.

Final testing of the transaction processing solution is underway and will be announced separately.

Management is discussing expansion of the Board of Directors in anticipation of new acquisitions and direct investment.

More from NOHO – in addition to the After Shot, we have developed a new line of products, all leveraging Hydro-Nano technology, which will be rolling out soon.  For additional information and product updates, please follow us at and follow NOHO on Twitter at

Cautionary Note Regarding Forward-Looking Statements.

This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Noho, Inc. (the “Company”), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.




Mcap MediaWire - Costumer Service

Translate »